Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma (Q43086833)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 March 2010
edit
Language Label Description Also known as
English
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
scientific article published on 30 March 2010

    Statements

    Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit